Funding for this research was provided by:
Israel Innovation Authority
Received: 22 September 2019
Accepted: 26 November 2019
First Online: 13 January 2020
: E.B. has no interests to disclose. N.D., N.B. and R.D.B. report having received grants from the Israel Innovation Authority during the conduct of this study. The parent company of Clalit Research Institute (N.D., N.B. and R.D.B.) owns a minority share in Zebra Medical Vision. E.E., O.B.A., A.B. and M.O. report personal fees from Zebra Medical Vision during the conduct of this study. In addition, E.E. and O.B.A. have a patent for emulating DXA scores based on CT images (WO2016013005A3) and a patent to predict osteoporotic fracture risk (WO2016013004A1).